Highlights
KLSE: PHARMA (7081)       PHARMANIAGA BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
2.42   +0.02 (0.83%)  2.41 - 2.42  11,400
Trade this stock for as low as 0.05% brokerage. Find out more.

Financials


Market Cap: 632 Million

Market Cap 632 Million
NOSH 261 Million

Latest Audited Result:  31-Dec-2017

Latest Audited Result: 31-Dec-2017
Announcement Date 13-Mar-2018
Next Audited Result: 31-Dec-2018
Est. Ann. Date: 13-Mar-2019
Est. Ann. Due Date: 29-Jun-2019

Latest Quarter:  30-Jun-2019 [#2]

Latest Quarter: 30-Jun-2019 [#2]
Announcement Date 23-Aug-2019
Next Quarter: 30-Sep-2019
Est. Ann. Date: 19-Nov-2019
Est. Ann. Due Date: 29-Nov-2019
QoQ | YoY   -52.69%  |    72.06%

Annual (Unaudited) ( EPS: 16.26, P/E: 11.75 )

Revenue | NP to SH 2,384,956  |  42,468
RPS | P/RPS 912.97 Cent  |  0.27
EPS | P/E | EY 16.26 Cent  |  11.75  |  8.51%
DPS | DY | Payout % 15.93 Cent  |  7.80%  |  98.01%
NAPS | P/NAPS 1.95  |  1.20
YoY   -21.10%
NP Margin | ROE 1.81%  |  8.33%
F.Y. | Ann. Date 31-Dec-2018  |  21-Feb-2019

T4Q Result ( EPS: 18.52, P/E: 13.07 )

Revenue | NP to SH 2,572,302  |  48,386
RPS | P/RPS 984.69 Cent  |  0.25
EPS | P/E | EY 18.52 Cent  |  13.07  |  7.65%
DPS | DY | Payout % 15.45 Cent  |  6.38%  |  83.39%
NAPS | P/NAPS 1.99  |  1.22
QoQ | YoY   8.74%  |    0.26%
NP Margin | ROE 1.90%  |  9.33%
F.Y. | Ann. Date 30-Jun-2019  |  23-Aug-2019

Annualized Result ( EPS: 22.12, P/E: 10.94 )

Revenue | NP to SH 2,775,996  |  57,796
RPS | P/RPS 1,062.66 Cent  |  0.23
EPS | P/E | EY 22.12 Cent  |  10.94  |  9.14%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -26.34%  |    25.75%
NP Margin | ROE 2.08%  |  11.15%
F.Y. | Ann. Date 30-Jun-2019  |  23-Aug-2019


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2019 23-Aug-2019 30-Jun-2019 2 601,890 12,481 9,262 9,281 6,514 518,564 70.19% 1.54% 1.79% 260,585 230.98 230.41 3.56 3.55 2.50 2.49 1.9900 1.99   -52.69%   72.06% 28-Jun-2019 2.84 1.23 79.74 1.43 1.25% 0.88% 23-Aug-2019 2.66 1.15 74.69 1.34 1.34% 0.94%
31-Dec-2019 16-May-2019 31-Mar-2019 1 786,108 30,243 19,648 19,617 15,630 528,825 79.68% 2.50% 3.71% 260,505 301.76 300.93 7.53 7.51 6.00 5.98 2.0300 2.02   342.12%   11.55% 29-Mar-2019 2.27 0.75 30.14 1.12 3.32% 2.64% 16-May-2019 2.36 0.78 31.34 1.16 3.19% 2.54%
31-Dec-2018 21-Feb-2019 31-Dec-2018 4 596,644 11,940 4,570 4,437 5,202 509,862 117.26% 0.77% 0.87% 260,134 229.36 228.40 1.71 1.70 2.00 1.99 1.9600 1.95   -70.52%   -79.55% 31-Dec-2018 2.78 1.21 162.99 1.42 0.61% 0.72% 21-Feb-2019 2.76 1.20 161.81 1.41 0.62% 0.72%
31-Dec-2018 19-Nov-2018 30-Sep-2018 3 587,660 17,603 15,305 15,051 13,000 522,618 86.38% 2.60% 2.88% 260,009 226.02 224.96 5.79 5.76 5.00 4.98 2.0100 2.00   179.03%   320.42% 28-Sep-2018 2.89 1.28 49.93 1.44 2.00% 1.73% 19-Nov-2018 3.09 1.37 53.38 1.54 1.87% 1.62%
31-Dec-2018 17-Aug-2018 30-Jun-2018 2 582,729 11,970 5,766 5,394 10,392 519,642 192.67% 0.99% 1.04% 259,821 224.28 223.07 2.08 2.06 4.00 3.98 2.0000 1.99   -69.33%   -43.34% 29-Jun-2018 2.88 1.28 138.73 1.44 0.72% 1.39% 17-Aug-2018 3.11 1.39 149.80 1.56 0.67% 1.29%
31-Dec-2018 16-May-2018 31-Mar-2018 1 617,923 28,707 17,589 17,586 12,991 524,838 73.87% 2.85% 3.35% 259,821 237.83 236.54 6.77 6.73 5.00 4.97 2.0200 2.01   -18.96%   -7.07% 30-Mar-2018 4.28 1.80 63.23 2.12 1.58% 1.17% 16-May-2018 4.07 1.71 60.13 2.01 1.66% 1.23%
31-Dec-2017 27-Feb-2018 31-Dec-2017 4 613,196 19,866 22,088 21,700 15,573 526,888 71.77% 3.60% 4.12% 259,551 236.25 234.73 8.36 8.31 6.00 5.96 2.0300 2.02   506.15%   2,695.69% 29-Dec-2017 4.60 1.95 55.02 2.27 1.82% 1.30% 27-Feb-2018 4.04 1.71 48.32 1.99 2.07% 1.49%
31-Dec-2017 15-Nov-2017 30-Sep-2017 3 574,503 15,271 3,890 3,580 12,973 531,892 362.37% 0.68% 0.67% 259,460 221.42 219.92 1.38 1.37 5.00 4.97 2.0500 2.04   -62.39%   -72.59% 29-Sep-2017 4.14 1.87 300.05 2.02 0.33% 1.21% 15-Nov-2017 3.82 1.73 276.85 1.86 0.36% 1.31%
31-Dec-2017 16-Aug-2017 30-Jun-2017 2 517,967 10,150 9,751 9,520 10,376 542,147 108.99% 1.88% 1.76% 259,400 199.68 198.28 3.67 3.64 4.00 3.97 2.0900 2.08   -49.69%   -36.51% 30-Jun-2017 4.58 2.29 124.80 2.19 0.80% 0.87% 16-Aug-2017 4.19 2.10 114.17 2.00 0.88% 0.95%
31-Dec-2017 16-May-2017 31-Mar-2017 1 618,294 27,777 19,258 18,923 10,368 544,360 54.79% 3.11% 3.48% 259,219 238.52 236.69 7.30 7.24 4.00 3.97 2.1000 2.08   2,363.52%   2.96% 31-Mar-2017 4.89 2.05 66.99 2.33 1.49% 0.82% 16-May-2017 4.72 1.98 64.66 2.25 1.55% 0.85%
31-Dec-2016 21-Feb-2017 31-Dec-2016 4 582,816 4,069 -900 -836 7,773 531,169 - % -0.15% -0.16% 259,107 224.93 223.10 -0.32 -0.32 3.00 2.98 2.0500 2.03   -106.40%   -105.20% 30-Dec-2016 5.30 2.36 -1,642.66 2.59 -0.06% 0.57% 21-Feb-2017 5.12 2.28 -1,586.88 2.50 -0.06% 0.59%
31-Dec-2016 21-Nov-2016 30-Sep-2016 3 515,215 19,923 12,648 13,061 10,365 531,250 79.37% 2.45% 2.46% 259,146 198.81 197.23 5.04 5.00 4.00 3.97 2.0500 2.03   -12.90%   -34.60% 30-Sep-2016 5.58 2.81 110.71 2.72 0.90% 0.72% 21-Nov-2016 5.70 2.87 113.10 2.78 0.88% 0.70%
31-Dec-2016 19-Aug-2016 30-Jun-2016 2 531,796 21,487 15,641 14,995 12,949 524,177 86.36% 2.94% 2.86% 258,981 205.34 203.57 5.79 5.74 5.00 4.96 2.0240 2.01   -18.41%   -7.54% 30-Jun-2016 5.50 2.68 94.99 2.72 1.05% 0.91% 19-Aug-2016 5.62 2.74 97.06 2.78 1.03% 0.89%
31-Dec-2016 13-May-2016 31-Mar-2016 1 559,195 26,538 18,470 18,379 10,354 515,906 56.34% 3.30% 3.56% 258,859 216.02 214.06 7.10 7.04 4.00 3.96 1.9930 1.97   14.43%   -42.19% 31-Mar-2016 5.76 2.67 81.13 2.89 1.23% 0.69% 13-May-2016 5.60 2.59 78.87 2.81 1.27% 0.71%
31-Dec-2015 15-Feb-2016 31-Dec-2015 4 680,150 23,717 16,041 16,062 18,134 529,786 112.90% 2.36% 3.03% 259,064 262.54 260.36 6.20 6.15 7.00 6.94 2.0450 2.03   -19.57%   -56.23% 31-Dec-2015 6.36 2.42 102.58 3.11 0.97% 1.10% 15-Feb-2016 6.19 2.36 99.84 3.03 1.00% 1.13%
31-Dec-2015 26-Nov-2015 30-Sep-2015 3 524,413 25,337 19,975 19,971 23,312 534,373 116.73% 3.81% 3.74% 259,027 202.45 200.75 7.71 7.64 9.00 8.92 2.0630 2.05   23.15%   33.54% 30-Sep-2015 6.50 3.21 84.31 3.15 1.19% 1.38% 26-Nov-2015 6.50 3.21 84.31 3.15 1.19% 1.38%
31-Dec-2015 17-Aug-2015 30-Jun-2015 2 512,845 25,056 16,642 16,217 18,134 528,477 111.82% 3.25% 3.07% 259,057 197.97 196.32 6.26 6.21 7.00 6.94 2.0400 2.02   -48.99%   1.51% 30-Jun-2015 7.13 3.60 113.90 3.50 0.88% 0.98% 17-Aug-2015 5.65 2.85 90.26 2.77 1.11% 1.24%
31-Dec-2015 18-May-2015 31-Mar-2015 1 471,904 38,612 31,926 31,794 18,123 528,173 57.00% 6.77% 6.02% 258,908 182.27 180.65 12.28 12.17 7.00 6.94 2.0400 2.02   -13.36%   21.27% 31-Mar-2015 6.00 3.29 48.86 2.94 2.05% 1.17% 18-May-2015 6.91 3.79 56.27 3.39 1.78% 1.01%
31-Dec-2014 23-Feb-2015 31-Dec-2014 4 627,103 37,854 36,621 36,697 31,055 525,351 84.63% 5.84% 6.99% 258,794 242.32 240.06 14.18 14.05 12.00 11.89 2.0300 2.01   145.38%   76.32% 31-Dec-2014 4.58 1.89 32.30 2.26 3.10% 2.62% 23-Feb-2015 5.28 2.18 37.24 2.60 2.69% 2.27%
31-Dec-2014 21-Nov-2014 30-Sep-2014 3 502,086 24,945 15,001 14,955 20,698 507,124 138.41% 2.99% 2.95% 258,737 194.05 192.20 5.78 5.72 8.00 7.92 1.9600 1.94   -6.38%   298.69% 30-Sep-2014 4.63 2.39 80.10 2.36 1.25% 1.73% 21-Nov-2014 4.45 2.29 76.99 2.27 1.30% 1.80%
31-Dec-2014 21-Aug-2014 30-Jun-2014 2 525,072 24,622 15,957 15,975 10,356 502,293 64.83% 3.04% 3.18% 258,914 202.80 201.00 6.17 6.12 4.00 3.96 1.9400 1.92   -39.07%   172.38% 30-Jun-2014 4.61 2.27 74.72 2.38 1.34% 0.87% 21-Aug-2014 4.62 2.28 74.88 2.38 1.34% 0.87%
31-Dec-2014 14-May-2014 31-Mar-2014 1 468,672 38,159 26,646 26,217 10,352 515,022 39.49% 5.69% 5.09% 258,805 181.09 179.41 10.13 10.04 4.00 3.96 1.9900 1.97   25.96%   5.84% 31-Mar-2014 4.46 2.46 44.03 2.24 2.27% 0.90% 14-May-2014 4.70 2.60 46.40 2.36 2.16% 0.85%
31-Dec-2013 24-Feb-2014 31-Dec-2013 4 567,860 33,007 21,267 20,813 16,049 486,672 77.11% 3.75% 4.28% 258,868 219.36 217.38 8.04 7.97 6.20 6.14 1.8800 1.86   454.87%   362.33% 31-Dec-2013 4.45 2.03 55.35 2.37 1.81% 1.39% 24-Feb-2014 4.29 1.96 53.36 2.28 1.87% 1.45%
31-Dec-2013 19-Nov-2013 30-Sep-2013 3 440,807 13,461 4,170 3,751 7,760 473,402 206.90% 0.95% 0.79% 258,689 170.40 168.74 1.45 1.44 3.00 2.97 1.8300 1.81   -36.04%   -85.14% 30-Sep-2013 4.82 2.83 332.41 2.63 0.30% 0.62% 19-Nov-2013 4.72 2.77 325.52 2.58 0.31% 0.64%
31-Dec-2013 16-Aug-2013 30-Jun-2013 2 437,633 9,605 6,171 5,865 8,810 480,568 150.22% 1.41% 1.22% 258,370 169.38 167.53 2.27 2.25 3.41 3.37 1.8600 1.84   -76.32%   -62.67% 28-Jun-2013 4.49 2.65 197.80 2.41 0.51% 0.76% 16-Aug-2013 4.66 2.75 205.29 2.51 0.49% 0.73%
31-Dec-2013 15-May-2013 31-Mar-2013 1 500,339 36,924 25,153 24,771 8,825 484,829 35.63% 5.03% 5.11% 117,676 425.18 191.53 21.05 9.48 7.50 3.38 4.1200 1.86   412.21%   -13.64% 29-Mar-2013 8.26 1.94 39.24 2.00 2.55% 0.91% 15-May-2013 9.26 2.18 43.99 2.25 2.27% 0.81%
31-Dec-2012 18-Feb-2013 31-Dec-2012 4 482,404 4,248 -7,468 -7,934 11,771 472,037 - % -1.55% -1.68% 117,715 409.81 184.67 -6.74 -3.04 10.00 4.51 4.0100 1.81   -131.43%   -166.44% 31-Dec-2012 8.10 1.98 -120.18 2.02 -0.83% 1.23% 18-Feb-2013 7.80 1.90 -115.73 1.95 -0.86% 1.28%
31-Dec-2012 06-Nov-2012 30-Sep-2012 3 426,460 28,493 25,536 25,247 11,764 496,469 46.60% 5.99% 5.09% 117,646 362.49 163.25 21.46 9.66 10.00 4.50 4.2200 1.90   60.68%   133.53% 28-Sep-2012 7.55 2.08 35.18 1.79 2.84% 1.32% 06-Nov-2012 8.25 2.28 38.44 1.95 2.60% 1.21%
31-Dec-2012 08-Aug-2012 30-Jun-2012 2 456,737 27,618 16,077 15,713 8,827 481,394 56.18% 3.52% 3.26% 117,700 388.05 174.84 13.35 6.02 7.50 3.38 4.0900 1.84   -45.22%   12.88% 29-Jun-2012 10.18 2.62 76.25 2.49 1.31% 0.74% 08-Aug-2012 8.83 2.28 66.14 2.16 1.51% 0.85%
31-Dec-2012 03-May-2012 31-Mar-2012 1 446,745 42,955 29,061 28,685 8,824 474,161 30.76% 6.51% 6.05% 117,657 379.70 171.02 24.38 10.98 7.50 3.38 4.0300 1.82   140.20%   85.26% 30-Mar-2012 5.90 1.55 24.20 1.46 4.13% 1.27% 03-May-2012 5.90 1.55 24.20 1.46 4.13% 1.27%
31-Dec-2011 22-Feb-2012 31-Dec-2011 4 367,786 16,368 12,182 11,942 35,296 514,153 295.57% 3.31% 2.32% 117,655 312.60 140.79 10.15 4.57 30.00 13.51 4.3700 1.97   10.46%   629.34% 30-Dec-2011 5.36 1.71 52.81 1.23 1.89% 5.60% 22-Feb-2012 5.90 1.89 58.13 1.35 1.72% 5.08%
31-Dec-2011 01-Nov-2011 30-Sep-2011 3 371,432 15,646 10,959 10,811 - 464,092 - % 2.95% 2.33% 106,933 347.35 142.19 10.11 4.14 0.00 0.00 4.3400 1.78   -22.33%   25.91% 30-Sep-2011 5.90 1.70 58.36 1.36 1.71% 0.00% 01-Nov-2011 5.90 1.70 58.36 1.36 1.71% 0.00%
31-Dec-2011 10-Aug-2011 30-Jun-2011 2 396,435 19,380 14,045 13,920 - 451,517 - % 3.54% 3.08% 106,994 370.52 151.76 13.01 5.33 0.00 0.00 4.2200 1.73   -10.10%   -5.61% 30-Jun-2011 5.90 1.59 45.35 1.40 2.21% 0.00% 10-Aug-2011 5.90 1.59 45.35 1.40 2.21% 0.00%
31-Dec-2011 13-May-2011 31-Mar-2011 1 385,328 21,792 15,599 15,484 - 437,661 - % 4.05% 3.54% 107,007 360.09 147.51 14.47 5.93 0.00 0.00 4.0900 1.68   786.35%   66.37% 31-Mar-2011 5.73 1.59 39.60 1.40 2.53% 0.00% 13-May-2011 5.05 1.40 34.90 1.23 2.87% 0.00%
31-Dec-2010 25-Feb-2011 31-Dec-2010 4 376,116 -2,701 -1,952 -2,256 - 421,262 - % -0.52% -0.54% 106,919 351.78 143.98 -2.11 -0.86 0.00 0.00 3.9400 1.61   -126.28%   -110.29% 30-Dec-2010 5.31 1.51 -251.66 1.35 -0.40% 0.00% 25-Feb-2011 5.35 1.52 -253.55 1.36 -0.39% 0.00%
31-Dec-2010 04-Nov-2010 30-Sep-2010 3 334,337 15,405 8,435 8,586 - 424,488 - % 2.52% 2.02% 106,924 312.69 127.99 8.03 3.29 0.00 0.00 3.9700 1.62   -41.78%   41.71% 30-Sep-2010 4.98 1.59 62.02 1.25 1.61% 0.00% 04-Nov-2010 4.92 1.57 61.27 1.24 1.63% 0.00%
31-Dec-2010 11-Aug-2010 30-Jun-2010 2 350,335 20,327 14,518 14,747 50,261 417,065 340.83% 4.14% 3.54% 106,939 327.60 134.11 13.79 5.65 47.00 19.24 3.9000 1.60   58.45%   -16.67% 30-Jun-2010 4.98 1.52 36.11 1.28 2.77% 9.44% 11-Aug-2010 4.95 1.51 35.90 1.27 2.79% 9.49%
31-Dec-2010 26-May-2010 31-Mar-2010 1 317,560 12,431 9,309 9,307 - 439,675 - % 2.93% 2.12% 106,977 296.85 121.56 8.70 3.56 0.00 0.00 4.1100 1.68   -57.53%   -35.91% 31-Mar-2010 4.27 1.44 49.08 1.04 2.04% 0.00% 26-May-2010 4.71 1.59 54.14 1.15 1.85% 0.00%
31-Dec-2009 19-Feb-2010 31-Dec-2009 4 323,906 27,490 22,118 21,914 39,590 431,217 180.66% 6.83% 5.08% 107,001 302.71 123.99 20.48 8.39 37.00 15.16 4.0300 1.65   261.68%   23.19% 31-Dec-2009 4.00 1.32 19.53 0.99 5.12% 9.25% 19-Feb-2010 4.05 1.34 19.78 1.00 5.06% 9.14%
31-Dec-2009 13-Nov-2009 30-Sep-2009 3 329,962 9,427 6,395 6,059 28,903 407,858 477.03% 1.94% 1.49% 107,049 308.23 126.31 5.66 2.32 27.00 11.06 3.8100 1.56   -65.76%   -42.79% 30-Sep-2009 4.09 1.33 72.26 1.07 1.38% 6.60% 13-Nov-2009 3.93 1.28 69.43 1.03 1.44% 6.87%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  2 people like this.
 
Jack888 Continue accumulate...
16/07/2019 6:01 AM
Jack888 Over sought....its time to collect more...
25/07/2019 2:45 PM
Vincent_8316 bought more at 2.56
01/08/2019 3:59 PM
Vincent_8316 bought lagi 2.49 yesterday and today 2.51
07/08/2019 3:34 PM
shareinvestor88 SELL SELL TP 1
10/08/2019 10:06 PM
Jack888 Its going to announce dividend soon...buy more.
15/08/2019 5:54 AM
ikenduit when div ex-date?
15/08/2019 9:48 AM
Jack888 Dividends distributed every quarterly....6.7% annually better than bank FD.
15/08/2019 11:30 AM
Jack888 https://www.youtube.com/watch?time_continue=354&v=YScyOu1i8To
15/08/2019 1:14 PM
Jack888 Start moving uptrend...
21/08/2019 9:40 AM
Hafid Halal Pharmaceuticals Industry 2019

Description:-

The global Halal Pharmaceuticals Market is anticipated to reach USD 34.82 billion by 2026.

The significant growth in the Halal Pharmaceuticals Market is primarily due to the rapid increase in the Muslim population, along with their improving disposable income. Increasing purchasing power and deepening belief in Shariah law together is responsible for creating a surge in demand for halal pharmaceuticals. Shariah law is derived from the Quran and is basically a collection of practices, words, habits, and silent approvals. As per the law, products containing the discharge of human beings or animals, and in direct or indirect contact with non-halal items. Moreover, it must not contain traces of things that are unfit for human consumption such as poison, and toxic elements.

Halal pharmaceuticals are expected to be prepared under a controlled environment to avoid any cross-contamination with non-halal utilities, materials, and ingredient. Extra care is taken in the manufacturing of these pharmaceuticals as no contamination will be tolerated. Rapid growth in demand has encouraged the Halal Pharmaceuticals Market players to actively indulge in activities that are aimed at or new product development.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/3695788-halal-pharmaceuticals-market-by-drug-class-allergies-endocrine

For more information or any query mail at sales@wiseguyreports.com

Growing Muslim population is showcasing a high interest in halal pharmaceuticals and cosmetics. This can be attributed to the increasing consumer awareness about the deepening beliefs and growing knowledge that pharmaceuticals contain alcohol, porcine-by products, and their derivatives, among other non-halal contents or ingredients that are against Islamic beliefs.

The Halal Pharmaceuticals Market experience tough challenge in defining proper regulation and standards. Recently, American pharmaceuticals companies expressed their concerns over the guidelines by Malaysia’s Ministry of Health (MOH). These guidelines were focused towards defining the permissible items in pharmaceuticals in accordance with Islam. The concern was highlighted in the annual submission to the United States Trade Representative by the Pharmaceutical Researchers and Manufacturers of America (PhRMA).

The Halal Pharmaceuticals Market has been segregated based on drug class, type, end-use, and region. By drug class, the market has been divided into allergies, endocrine drugs, pain medications, respiratory drugs, and others. By type, the market has been bifurcated into capsule, syrup, and tablet. The industry experience high demand for end-use applications such as drugs, cosmetics, healthcare, and others.

The Middle East and the Asia Pacific regions Halal Pharmaceuticals Market are expected to witness significant growth in the next eight years due to the presence of a large population of Muslims. Majority of the Muslim population of the world lives in these regions, and they also comprise of emerging nations such as India, Indonesia, Malaysia, Bangladesh, Maldives, and Pakistan that have a high population that follows Islamic beliefs.

The list of key companies that are operating in the Halal Pharmaceuticals Market includes Chemical Company of Malaysia Berhad, Rosemont Pharmaceuticals, Bosch Pharmaceuticals, Noor Vitamins, EMBIL Pharmaceutical Co., Ltd, Nutramedica Incorporated, Pharmaniaga Bhd, and SimporPharmaSdnBhd, among others.
22/08/2019 4:10 PM
Stocker QR release soon
23/08/2019 12:19 PM
Stocker Good ~ monday go up
23/08/2019 5:56 PM
kalofarmako It's going up time to buy ! Come on gaiss.

https://klse.i3investor.com/blogs/MYpharmaceuticalnews/221505.jsp
26/08/2019 10:51 AM
Hafid Risk is the concession renewal which expired in Nov 2029
26/08/2019 2:47 PM
Hafid Expired in 2019
26/08/2019 2:47 PM
Hafid Sarawak will have own medical service, same to sabah
26/08/2019 2:48 PM
mukhriz02023 Layan musang king dulu guys.
26/08/2019 3:22 PM
kalofarmako Pharmaniaga’s focus on non-concession ops seen to boost profit

https://www.klsescreener.com/v2/news/view/572140
28/08/2019 9:57 AM
kalofarmako Morning!

"High time to decide on concession issue"

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/222426.jsp
30/08/2019 9:53 AM
supergreat should take a look on kotra pharma (0002). It's cash flow and profit keep improving.
30/08/2019 2:57 PM
kalofarmako WOW!!

The positive long-term outlook for Pharmaniaga

Read more: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/223457.jsp
05/09/2019 1:09 PM
kalofarmako DHM explained that Pharmaniaga is only responsible for the logistics of supplying drugs to government health facilities, rather than the supply itself.

Check out here: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224313.jsp
11/09/2019 10:56 AM
rajachulan I had stopped buying any stock which dealing with gomen... many months ago... after i have seen how gomen play construction sector...

gdluck buying stock dealing with gomen...
11/09/2019 11:00 AM
rajachulan another round of national treasure redistribution in progress... just wait till the dust settled...
11/09/2019 11:03 AM
kalofarmako “The big problem is price control, not Pharmaniaga,” says MyCC

Social activist Lim Mah Hui, one of the conductors of the MyCC study, said Pharmaniaga did not have a monopoly over supply but a virtual monopoly over logistics.

Check out: https://klse.i3investor.com/blogs/MYpharmaceuticalnews/224759.jsp
13/09/2019 9:52 AM
rajachulan no doubt... healthcare and insurance are two industries APAC to grow next few decade... however... if the govt !@#$%^&*()... then !@#$%^&*()
13/09/2019 10:07 AM
ikenduit Actually there are 2 multinational companies main logistic and distributor of Healthcare products for Malaysia market. What pharmaniaga handle only small fraction and not monopoly. Ask people in industry.
13/09/2019 2:05 PM
Hafid Need to drop to rm2.00
17/09/2019 10:40 AM
patrick2 price drop....chances of renewing govt concession getting slim??
17/09/2019 10:53 PM
kalofarmako Ex-Health DG Ismail Merican Quits Pharmaniaga Board: https://codeblue.galencentre.org/2019/10/01/ex-health-dg-ismail-merican-quits-pharmaniaga-board/

Im so glad that this culprit is no longer in Pharmaniaga. Have you guys tried to read about his scandal and 9bio? From a reliable source confirming Ekovest Berhad in control of 9Bio project. Secured turnkey design-and-build concept being manipulated with the help of Datuk Lim Kang Hoo and assisted from inside MOH by Tan Sri Ismai Merican to inflate the estimated project cost from RM350 million to RM1.9 billion. The government originally agreed and approved only RM350 million. Imagine the amount of potential kickbacks?

Can google Ismail Merican + 9bio for more information
02/10/2019 8:25 PM
AllanTingAS I also think Pharmaniaga contract will be extended as there are no alternative. Further more, major SH are government GLCs. Question is went to enter under today uncertain world economy.
06/10/2019 10:14 PM
patrick2 who is KKM?
07/10/2019 4:14 PM
rajachulan MOH...
07/10/2019 4:19 PM
kalofarmako The public need to understand that Pharmaniaga's role as a concessionaire and not immediately liken it to a monopoly. Shared some thoughts in this article (https://klse.i3investor.com/blogs/MYpharmaceuticalnews/228733.jsp). Though it could use a bit more context but hope this can get the conversation going.

Source: http://read.focusmalaysia.my/ePaper/xml_epaper/Focus/05_10_2019/pla_1_Standard/xml_arts/art_52429.htm
07/10/2019 4:23 PM
patrick2 ok thanks
07/10/2019 5:03 PM
Think Government will not likely to announce discontinuation last minute. That would disrupt the medicine supply chain. Either they will announce another 10 years concession or subject Pharmaniaga to annual renewal. Latter is more likely.
Now everyone waits and sees. When contract announced, that would send Pharmaniaga to new high. The price has been supressed for long.
07/10/2019 9:39 PM
AllanTingAS KKM Kementerian Kesihatan Malaysia
07/10/2019 10:27 PM
patrick2 ok tq
07/10/2019 11:41 PM
rajachulan name one company who really celebrating in getting a contract from this govt ....
09/10/2019 10:51 AM
patrick2 already confirmed? but price go down again today
09/10/2019 4:04 PM
patrick2 yesterday got somebody said is confirm, but his name was disappeared after that...
10/10/2019 10:30 AM
patrick2 further selling today....
10/10/2019 3:24 PM
7300 beneifciary of budget tax cut
10/10/2019 5:45 PM
nhy6 sure anot, shared prosperity or shared poverty...
10/10/2019 5:47 PM
patrick2 any news on concession contract?
13/10/2019 10:35 AM
Wirajati Confident they got it. Nothing official though. All big owners are still holding pharmaniaga. So should we.
13/10/2019 5:46 PM
patrick2 ok thanks
14/10/2019 12:01 AM
patrick2 PHARMA COMING....
15/10/2019 10:26 AM
ikenduit Very soon
17/10/2019 5:49 PM